Health ❯ Healthcare ❯ Clinical Research

Efficacy Studies

Phase 3 Trials Comparative Effectiveness Randomized Controlled Trials ESSENCE-TIMI 73b Trial BaxHTN Trial HIV Prevention AMT-130 DREAMS-3 Trial Agitation Management Semaglutide Trials TRuE-AD3 Trial Higher Doses Safety Assessments VYVGART VER-01 Study LUCENT-3 Study Survival Outcomes Real-World Evidence Tirzepatida in Sleep Apnea Phase 2 Trials DELIVER Trial TRIUMPH-4 Trial STARBORN-1 Trial STEP UP Trial Endpoints in Clinical Trials Placebo-Controlled Trials Novo Nordisk Patient Outcomes

Dyne’s DMD Drug Hits Primary Endpoint in DELIVER REC, Shows Functional Gains

The readout gives Dyne a path to an accelerated approval filing in 2026.

Protara Reports Strong Interim Phase 2 Results for TARA-002 in Pediatric Lymphatic Malformations

Innovent Says Mazdutide Tops Semaglutide in China Phase 3 Diabetes Trial

EMA Panel Recommends Rejecting Rezurock for Chronic Graft-Versus-Host Disease in EU

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Cochrane Review Finds RSV Vaccines Protect Older Adults and Infants Without Raising Serious Risks

Moonlake Shares Plunge on Mixed Phase 3 Results for Hidradenitis Drug

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials